Berton, M.
, Howard, K., Benimetskaya, L., Allemann, E., Weil, R., Zwillenberg, L. O., Stein, C. A. & Gurny, R. (1997).
Uptake of oligonucleotide loaded nanoparticles in prostatic cancer cells and their intracellular localization.
Proceedings of the Controlled Release Society, (24), 669-670.
Decuzzi, P., Peer, D., Di Mascolo, D., Palange, A. L., Manghnani, P. N., Moein Moghimi, S., Shadi Farhangrazi, Z.
, Howard, K. A., Rosenblum, D., Liang, T., Chen, Z., Wang, Z., Zhu, J. J., Gu, Z., Korin, N., Letourneur, D., Chauvierre, C., van der Meel, R., Kiessling, F. & Lammers, T. (2021).
Roadmap on nanomedicine.
Nanotechnology,
32(1), Article 012001.
https://doi.org/10.1088/1361-6528/abaadb
Hangiu, O., Compte, M.
, Dinesen, A., Navarro, R., Tapia-Galisteo, A.
, Mandrup, O. A., Erce-Llamazares, A., Lázaro-Gorines, R., Nehme-Álvarez, D., Domínguez-Alonso, C.
, Harwood, S. L., Alfonso, C., Blanco, B., Rubio-Pérez, L., Jiménez-Reinoso, A., Díez-Alonso, L., Blanco, F. J., Sanz, L.
, Howard, K. A. & Álvarez-Vallina, L. (2022).
Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity.
iScience,
25(9), Article 104958.
https://doi.org/10.1016/j.isci.2022.104958